Pharmaceutical Technology, Sep 1, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Sep 1, 2011
Articles
Manufacturing Perspectives: Lessons for Biomanufacturing from Small-Molecule Manufacturing
By Lou Schmukler
A perspective from Pfizer on the lessons from small-molecule manufacturing that can be applied to biomanufacturing.
Building Technology Positions in API Manufacturing
By Patricia Van Arnum
As contract manufacturers and fine-chemical suppliers gather for CPhI/ICSE, effective strategies for technology differentiation are key in an increasingly competitive environment.
FDA's New Process Validation Guidance: Industry Reaction, Questions, and Challenges
By Mike Long , Hal Baseman , Walter D. Henkels
The authors desribe the three-stage approach to validation that is outlined in the new guidance and discuss questions surrounding implementation.
The Determination and Control of Genotoxic Impurities in APIs
By V. Gangadhar , Y. Pardha Saradhi , R. Rajavikram
The authors provide an overview of methods for the quantitative determination of genotoxic impurities (GTIs) in active pharmaceutical ingredients.
Sample Preparation for Quantitative Metal Impurity Testing
By Gayla Velez
The author examines sample-preparations methods used in inductively coupled plasma–optimal emission spectroscopy for four test metals.
Achieving Containment in High-Potency Manufacturing: A Case Study for Solid Dosage Manufacturing
A Q&A with Joe Cascone, director of potent pharmaceutical development at Metrics, moderated by Patricia Van Arnum. Discussion of the key considerations made in facility design, equipment selection, and operations to achieve desired levels of containment.
A Supplier's Role in Ensuring and Improving Excipient Quality
By Frithjof Holtz , Najib Sehat
Excipients are the hidden champions of drug development—no API works consistently without the right excipient. Pharmaceutical excipients, however, require stringent quality management. This article discusses how the supplier of pharmaceutical raw materials should take a central role in ensuring excipient quality.
Addressing Ways to Improve Supply-Chain Security: A Perspective from Pfizer
A Q&A with Brian Johnson, senior director of supply chain security at Pfizer, moderated by Patricia Van Arnum. Part of a special Ingredients issue.
Atypical Actives Gain Attention
By Angie Drakulich
Clarifying GMPs for excipients used as actives.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
42%
Facility/environment problems
0%
Process development problems
8%
Production equipment downtime
8%
Raw material supply problems
25%
Regulatory restrictions
0%
Business decisions to limit production
17%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Click here